13F Pro

SEC Form 4 reporting owner

Farnum Rhonda

Farnum Rhonda has filed 20 Form 4 transactions reported between November 20, 2025 and September 23, 2026, as SVP, COMM & MEDICAL AFFAIRS of Theravance Biopharma, Inc..

Name as filed: Farnum Rhonda

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$1.5M
12 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 23, 2026
transaction date

Roles and reported holdings

  • TBPHTheravance Biopharma, Inc.
    Nov 20, 2025 – Sep 23, 2026

    SVP, COMM & MEDICAL AFFAIRS

    Held directly213,476 sh as of Sep 15, 2026 · Form 4

    24 months: $1.5M sold

Transaction history

All 20 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 23, 2026TBPHSVP, COMM & MEDICAL AFFAIRSDisposition to issuerCode D · direct150,000—Form 4
Sep 23, 2026TBPHSVP, COMM & MEDICAL AFFAIRSDisposition to issuerCode D · direct89,062—Form 4
Sep 23, 2026TBPHSVP, COMM & MEDICAL AFFAIRSDisposition to issuerCode D · direct124,414—Form 4
Sep 15, 2026TBPHSVP, COMM & MEDICAL AFFAIRSOpen-market saleCode S · direct6,657$113K@ $17.03Form 4
Sep 15, 2026TBPHSVP, COMM & MEDICAL AFFAIRSOpen-market saleCode S · direct3,328$57K@ $17.03Form 4
Sep 15, 2026TBPHSVP, COMM & MEDICAL AFFAIRSOpen-market saleCode S · direct3,329$57K@ $17.03Form 4
Aug 20, 2026TBPHSVP, COMM & MEDICAL AFFAIRSShares withheld for tax or exercise priceCode F · direct5,667$96K@ $16.95Form 4
Jun 15, 2026TBPHSVP, COMM & MEDICAL AFFAIRSOpen-market saleCode S · direct6,657$109K@ $16.39Form 4
Jun 15, 2026TBPHSVP, COMM & MEDICAL AFFAIRSOpen-market saleCode S · direct3,328$55K@ $16.38Form 4
Jun 15, 2026TBPHSVP, COMM & MEDICAL AFFAIRSOpen-market saleCode S · direct3,329$55K@ $16.39Form 4
May 20, 2026TBPHSVP, COMM & MEDICAL AFFAIRSShares withheld for tax or exercise priceCode F · direct5,678$94K@ $16.55Form 4
Apr 1, 2026TBPHSVP, COMM & MEDICAL AFFAIRSGrant or awardCode A · direct18,750—Form 4
Mar 16, 2026TBPHSVP, COMM & MEDICAL AFFAIRSOpen-market saleCode S · direct7,766$108K@ $13.92Form 4
Mar 16, 2026TBPHSVP, COMM & MEDICAL AFFAIRSOpen-market saleCode S · direct15,534$217K@ $14.00Form 4
Mar 16, 2026TBPHSVP, COMM & MEDICAL AFFAIRSOpen-market saleCode S · direct7,767$108K@ $13.92Form 4
Feb 20, 2026TBPHSVP, COMM & MEDICAL AFFAIRSShares withheld for tax or exercise priceCode F · direct13,929$274K@ $19.66Form 4
Dec 3, 2025TBPHSVP, COMM & MEDICAL AFFAIRSOpen-market saleCode S · direct15,534$291K@ $18.75Form 4
Dec 3, 2025TBPHSVP, COMM & MEDICAL AFFAIRSOpen-market saleCode S · direct7,766$146K@ $18.75Form 4
Dec 3, 2025TBPHSVP, COMM & MEDICAL AFFAIRSOpen-market saleCode S · direct7,767$146K@ $18.75Form 4
Nov 20, 2025TBPHSVP, COMM & MEDICAL AFFAIRSShares withheld for tax or exercise priceCode F · direct9,060$162K@ $17.90Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.